Back to Trials
NCT06841198NARecruitingAccepts Healthy Volunteers

Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury

Kessler Foundation

Start Date

4/1/2025

Completion Date

11/1/2026

Summary

The study aims to explore how cardiovascular function changes in the first year after a spinal cord injury, and to see how different treatments, like spinal stimulation through the skin (transcutaneous spinal stimulation), affect blood pressure. The main questions are: How does stimulation affect blood pressure over the year? What is the level of cardiovascular activation throughout the year? The study will start during the inpatient stay at the Kessler Institute for Rehabilitation and continue after discharge as an outpatient, totaling about 20-29 sessions over the year.

Detailed Description

This clinical study investigates the cardiovascular effects of spinal cord transcutaneous stimulation (scTS) in individuals with recent spinal cord injury (SCI), examining how blood pressure response to stimulation evolves over the first year post-injury. The primary objectives are to determine the optimal timing for initiating scTS for cardiovascular control, characterize blood pressure response evolution to stimulation over one year, and assess autonomic activation patterns through multiple testing methods. The study will recruit five individuals with recent SCI, specifically targeting those who are 50 days or less post-injury, with an injury level at or above T6, and classified as American Spinal Injury Association Impairment Scale (AIS) A/B. All participants must present with low blood pressure and orthostatic hypotension and be between 18-75 years of age. The study protocol is divided into inpatient and outpatient phases. During the inpatient phase, consisting of 5-11 sessions, participants undergo a basic assessment including autonomic dysfunction questionnaires, 24-hour blood pressure monitoring, cold pressor testing, and tilt tests with and without stimulation. The protocol also includes 2-3 days of stimulation mapping. The outpatient phase spans 15-18 sessions over the remainder of the year. Participants undergo monthly mapping sessions and autonomic dysfunction assessments, with comprehensive autonomic testing conducted at 6, 9, and 12 months post-injury. Throughout both phases, researchers perform stimulation mapping across various spinal segments (thoracic, lumbosacral) using a 5-channel electrical stimulator, while monitoring blood pressure and electromyography to target a blood pressure range of 110-120 mmHg. The study employs multiple assessment tools, including 70° tilt tests with orthostatic symptom evaluation every 5 minutes, cold pressor tests, autonomic dysfunction questionnaires, and 24-hour ambulatory blood pressure monitoring. The study aims to track primary outcomes including blood pressure response to stimulation at different time points, evolution of orthostatic hypotension symptoms and management, and the pattern of autonomic dysfunction development post-injury. A spin-off study is conducted to determine which cold-pressor intervention yields the most stable and consistent blood pressure response. This supplementary study compares 5 individuals with chronic SCI and 5 able-bodied controls. The findings from this spin-off study will directly inform the intervention protocol used in the main study.

Eligibility Criteria

Age Range: 18 years to 75 years

For the main study: Inclusion Criteria: * Individuals with a spinal cord injury undergoing inpatient rehabilitation at the Kessler Institute for Rehabilitation * Between 18-75 years old * 7-50 days after injury * Injury level ≥ T6 (a cervical or a high-level chest injury) * Individuals experiencing low blood pressure after the injury * American Spinal Injury Association Impairment Scale (AIS) A or B Exclusion Criteria: * A ventilator is needed for breathing. * Devices such as brain/spine/nerve stimulators, a cardiac pacemaker/defibrillator, or intra-cardiac lines are present in the body. * There is a significant disease affecting the blood vessels or signals in the heart, or a recent heart attack (myocardial infarction) has occurred. * A new medication has been prescribed to treat blood pressure or a heart problem within the last five days (excluding midodrine). * There is a known infection in the body (e.g., urinary tract infection) or a current illness (e.g., recent diagnosis of deep vein thrombosis (DVT) or other blood clotting issues, and/or a pressure injury that might interfere with the study). * There is a history of seizures. * Pregnancy. For the spin-off study ice-water vs ice-wrap test (see description in study arms): \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Inclusion: Age 18-75. Inclusion for individuals with SCI: * Injury sustained more than 6 months ago * Injury level ≥ T6 (a cervical or a high-level chest injury) * American spinal injury association impairment scale (AIS) A - D Exclusion: Foot lesions, uses a ventilator, devices such as brain/spine/nerve stimulators, significant or recent cardiovascular disease, known infection in the body

Interventions

DEVICE

spinal cord transcutaneous stimulation

PROCEDURE

Ice testing

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Spinal Cord Injuries (SCI)Orthostatic Hypotension, DysautonomicCardiovascularTranscutaneous Spinal Stimulation

Locations

Kessler Foundation

West Orange, New Jersey 07052

United States